Compartir
Commercializing Nanomedicine: Industrial Applications, Patents, and Ethics (en Inglés)
Luca Escoffier
(Autor)
·
Mario Ganau
(Autor)
·
Julielynn Wong
(Autor)
·
Jenny Stanford Publishing
· Tapa Dura
Commercializing Nanomedicine: Industrial Applications, Patents, and Ethics (en Inglés) - Escoffier, Luca ; Ganau, Mario ; Wong, Julielynn
$ 835.80
$ 1,671.60
Ahorras: $ 835.80
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Viernes 21 de Junio y el
Miércoles 03 de Julio.
Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Commercializing Nanomedicine: Industrial Applications, Patents, and Ethics (en Inglés)"
The authors of this book address all individuals approaching the study of nanomedicine for the first time ever, as well as those already profitably working in the field either as scientists, doctors, lawyers, or entrepreneurs. Teeming with accurate, up-to-date, and enjoyable content, the book describes some enlightening facts and figures pertaining to the growing field of nanomedicine. Open problems and potentialities are identified and discussed, offering a series of forecasts regarding its global impact on healthcare systems in the coming two decades. This introduction is followed by three different sections: (a) one purely scientific, which delves deep into areas as diverse as proteomics or delivery systems for nanodrugs, demonstrating how nanotechnology is reshaping the way diagnosis and treatment of diseases are made; (b) one focused on the ethical challenges that governments and companies are facing or will have to face in order to protect patients' rights; and (c) one entirely dedicated to the legal and entrepreneurial issues that are driving this entire medical revolution. In the pages of this lucidly written book, scientists and managers will certainly find the need-to-have tool on their desk to thrive and succeed in the commercialization of nanomedicine.
